3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of biological products, recently awarded the...

Read more

3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA

by 3P Biopharmaceuticals

The investments will enable the company to increase its mammalian cell-based protein production capacity tenfold and increase its microbial cell-based protein production capacity by 50%. The total flo...

Read more

3P Biopharmaceuticals appoints Diego Bochoeyer as Director of Strategic Development and Supply Chain

by 3P Biopharmaceuticals

3P Biopharmaceuticals incorporates a new member to the executive management team by engaging Diego Bochoeyer as Director of Strategic Development and Supply Chain.

Read more

3P Biopharmaceuticals enters into alliance with Precirix to develop precision radiopharmaceuticals in oncology

by 3P Biopharmaceuticals

3P Biopharmaceuticals and Precirix NV have signed an agreement for the clinical manufacturing of a camelid single-domain antibody fragment (sdAb), the backbone of Precirix’ next product candidate to...

Read more

3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to combat solid tumours

by 3P Biopharmaceuticals

3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.

Read more

3P Biopharmaceuticals y Buzzard Pharmaceuticals inician una colaboración para desarrollar un nuevo tratamiento oncológico

by 3P Biopharmaceuticals

3P se ocupará de la fabricación cGMP de Isunakinra, un medicamento contra tumores sólidos, que se encuentra en fase I/II de desarrollo en pacientes en EEUU

Read more

La esperanza de reducir las complicaciones cardiovasculares asociadas a la diálisis

by 3P Biopharmaceuticals

Las empresas biotecnológicas Invizius y 3P Biopharmaceuticals colaboran en una tecnología innovadora para los pacientes que se someten a hemodiálisis y sufren de enfermedades cardiovasculares

Read more

3P Biopharmaceuticals y SpyBiotech firman un contrato para la fabricación de vacunas

by 3P Biopharmaceuticals

3P Biopharmaceuticals, compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo normas de correcta fabricación (cGMPs) de medicamentos biológicos y productos de...

Read more

BioPharm America Digital (September 21–24, 2020)

by 3P Biopharmaceuticals

We are looking forward to participating in BioPharm America Digital during the week of September 21–24.

Read more

3P Biopharmaceuticals nombra a Iker Portugal como Director Financiero Corporativo

by 3P Biopharmaceuticals

Es un profesional con dilatada experiencia en el sector financiero y se une a 3P para impulsar el crecimiento de la compañía

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

CNIO promotes the use of artificial inte...

by CNIO - Centro Nacional de Investigaciones Oncológicas

The National Cancer Research Centre (CNIO) will create a new artificia...

Photos Stream